PATENT CLAIM ANALYSIS

Application Number: 15772699
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-08
Patent Classification: ["514", "254000"]

Abstract:
Provided are ARTS mimetic compounds that act as novel antagonists for XIAP and Bcl-2. Further, the novel ARTS mimetic compounds of the presently claimed subject matter induce apoptosis and/or differentiation in premalignant and malignant cells and thereby restore their normal-like phenotype. Further provided are compositions, methods and uses of said ARTS mimetic compounds in the treatment of cancer and premalignant conditions.

Claim (Index 62):
The method according to  claim 61 , wherein said cell is any one of a premalignant epithelial breast cell and an epithelial breast carcinoma cell, and wherein said ARTS mimetic compound induces formation of acini-like organoids characterized by a hollow lumen by said epithelial breast cells reminiscent of the normal breast tissue.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 93.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11632079', '12270374', '11800220', '10586271', '14386747']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7800669923123843
- 35 USC 102 Novelty (BERT): 0.5347697894375602
- Combined Prediction Score: 0.755537272024902
- Mean Citation Score: 296.802926
- Max Citation Score: 340.8475
- Similarity Product: 148.24107405677438

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test